Press Release | August 2, 2022
Smart Meter’s Launches New Patient Engagement Program that is 94% Effective in Helping Improve Patient Adherence
Smart Meter has a great solution for patients with COPD or Long COVID
Using the iPulseOx, the world’s first cellular-enabled pulse oximeter, in combination with our iBloodPressure is an excellent way to see key measurements of COPD and Long COVID patients. And now
you can purchase both of these solutions at one low price.
Contact your Account Representative or send an
email to info@iglucose.com to learn more.
SmartTouch is Guaranteed to
Increase Patient Engagement
SmartTouch is Smart Meter’s turnkey, branded outreach program that is proven to increase testing adherence in the critical first 30-day window of use and beyond.
Our iScale can help solve the weight management issue in the US
Obesity has reached endemic proportions
in the United States. Our cellular-enabled iScale is a simple
way to help manage weight by sending data directly to a provider. We are currently offering it at an even more affordable price. Contact your Account Representative or send
an email to info@iglucose.com to learn more.
Our CVD Bundle Special is Back
Due to overwhelming customer demand,
we are extending the specially priced
cardiovascular disease (CVD) bundle that
includes our cellular-enabled
blood pressure monitor and scale.
Get Closer To The Patient
With Data and Solutions Infrastructure for
Remote Patient Monitoring and
Chronic Care Management
Smart Meter is the foundation of the RPM Ecosystem
Smart Meter’s unique cellular technology facilitates the delivery of reliable, accurate patient testing data seamlessly to healthcare professionals via our customers’ platform.
Smart Meter is the foundation of the RPM Ecosystem
Smart Meter’s unique cellular technology facilitates the delivery of reliable, accurate patient testing data seamlessly to healthcare professionals via our customers’ platform.
Our Cellular-Connected Devices
US Patent Nos.: 10,311,208; 10,783,987; 10,783,988. UK Patent No. GB2542056. Canada Patent No. 2953253
Now Available with an Extra-Large Cuff
Our Cellular-Connected Devices
US Patent Nos.: 10,311,208; 10,783,987; 10,783,988. UK Patent No. GB2542056. Canada Patent No. 2953253
Current Partners
Join the hundreds of market-leading RPM companies utilizing Smart Meter’s powerful cellular SmartRPM technology.
Smart Meter by the Numbers
350+
Distribution Partners
130,000+
Patients Monitored Daily
2M+
Monthly Patient Tests
99.9%
Device reliability1
Smart Meter by the Numbers
350+
Distribution Partners
130,000+
Patients Monitored Daily
2M+
Monthly Patient Tests
99.9%
Device reliability1
Cellular Remote Patient Monitoring:
Immediate. Reliable. Actionable.
Smart Meter eliminates the complex, extra steps—and delay—of sharing health metrics. All patients do is test by pressing a single button on iGlucose, iBloodPressure, iPulseOx or simply stepping on the iScale. Clinicians benefit from access to cellular transmitted, real-time, reliable and secure patient data between visits, which can lead to better patient out comes.
Testimonials
"iGlucose’s ability to send BG data to our platform without syncing, pairing, home hubs or cables, is the perfect solution."– Joshua Claman, Former Chief Executive Officer, Rimidi
"Data flowing into the population management portal has quickly become an essential tool in managing diabetes for our patients. …iGlucose system drives better outcomes for our patients."– Joel Okner, MD, Cardiologist
"The iGlucose system with real-time data adds tremendous value to our diabetes education program ... The ability to have real-time data in making therapy decisions has been a huge plus."– Vivian N. Ayuk, PharmD, CDE, Chief Executive Officer, Flexcare Health Solutions
"Because of the remote patient monitoring available with your iGlucose meters, we will discuss the utility of remote patient monitoring for many patients. I can’t thank your company enough for enabling our future physicians an opportunity to gain an understanding of what they might ask of their future patients. "– Kathryn R Goldman, MD, Assistant Professor of Medicine, University of Connecticut School of Medicine
News + Events
Smart Meter’s Launches New Patient Engagement Program that is 94% Effective in Helping Improve Patient Adherence
Read More | August 2, 2022
News Release | July 18, 2022
Diabetes Travel Essentials and Tips for the Approximately 21 Million Americans that Must Manage Their Diabetes While on Vacation
Smart Meter partners with AT&T IoT for better health outcomes
Read More | January 3, 2022
*Better Data. Better Care. Better Outcomes. Reference: Self-Monitoring of Blood Glucose: A Prerequisite for Diabetes Management in Outcome Trials Oliver Schnell, MD1, Markolf Hanefeld, MD2, and Louis Monnier, MD3
1 – 99.9% of active patients have zero product issues based on over 2 million clinical readings March – August 2021.